Fagron NV (ARSUF)
Summary
Fagron NV (ARSUF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Fagron NV ever had a stock split?
Fagron NV Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Rafael Padilla CEO | OTC PINK Exchange | BE0003874915 ISIN |
| BE Country | 4,193 Employees | - Last Dividend | 17 Jun 2016 Last Split | - IPO Date |
Overview
Fagron NV is a globally operating pharmaceutical compounding company, dedicated to offering personalized pharmaceutical care to a broad range of healthcare facilities and patients. The company categorizes its operations into three main segments: Essentials, Brands, and Compounding Services. It is actively engaged in the innovation of concepts, vehicles, and formulations to advance pharmaceutical compounding. Founded in 1990 and originally known as Arseus NV, the company underwent a name change to Fagron NV in January 2015 and has since established its base in Nazareth, Belgium. Fagron's mission is to bridge the gap between the unique needs of patients and the capabilities of the pharmaceutical industry by providing custom solutions. To support this mission, it also runs the Fagron Academy, which offers education and training to pharmacists and prescribers.
Products and Services
- DiluCap: These are a range of excipients designed to assist in the compounding of capsule formulations, catering to a variety of pharmaceutical needs.
- Imuno TF Complex: This product aids in the regulation of immune responses, offering support in immune system regulation.
- Pigmerise: Targeted at those suffering from hypopigmentation disorders, Pigmerise utilizes a natural phytocomplex to address these conditions.
- Pentravan: A cream base designed to enhance the delivery of medications by avoiding first-pass metabolism and preventing gastrointestinal erosion, thus ensuring effective therapy.
- Nourisil MD: Recommended as a first line therapy, this product aids in the prevention and treatment of scars and keloids, offering both curative and preventive benefits for skin health.
- Neogen: This line of hair care products addresses various needs and conditions, including hair loss, with a focus on promoting hair health and growth.
- TrichoConcept: Specifically formulated for the treatment of alopecia, this range offers targeted solutions for those experiencing hair loss.
- Fagron Advanced Derma: Focused on skincare, this portfolio covers basic skin care needs, compound pharmaceutical treatment options, and personalized dermatological care, catering to individual requirements.
- SyrSpend SF: This range ensures pharmaceutical stability, consistency in dosage, and patient comfort, improving the overall medication administration experience.
